News Center

Declaration

2021-11-10

Sihuan Metformin Hydrochloride Tablet Passes Consistency Evaluation

2018-12-17

The product’s successful passing the consistency evaluation is the authoritative recognition of Sihuan's R&D capability, production and product quality and product efficacy, and also gives it an advantage in future market access, medical insurance payment and other areas.

Sihuan Officially Starts Phase II Clinical Trial on Pirotinib in China

2018-08-14

Sihuan Pharmaceutical Holdings Group Co., Ltd. (HKEx stock code 00460), a cardio-cerebral vascular drug manufacturer in the Chinese prescription drug market, announces that, Pirotinib, an innovative anti-tumor drug independently developed by it, has completed Phase I clinical trial in the United States and officially started Phase II clinical trial in China

Che Fengsheng and His Team Visit Jiulongpo Hospital 2 for Work Guidance

2018-06-26

On June 24, 2018, Che Fengsheng, Chairman of the Board of Directors and President of the Group, Wang Xin, Secretary of the Party Committee of Zhongshan Hospital of Fudan University, Gao Fabao, Professor of West China Hospital of Sichuan University, and other experts, accompanied by Li Hongliang, Deputy Head of Jiulongpo District, Chongqing, visited the Second People's Hospital of Jiulongpo District, Chongqing (Jiulongpo Hospital 2) for work guidance. Jia Fei, Director of Government Office of the

I Am A "Bottle Shaker" Whose One False Step Will Make A Great Difference

2018-06-12

Lu Yanan Quality Control Department of Sihuan Pharmaceutical Innovative Drug R&D Center